Free Trial

Morgan Stanley (MS) Stock Forecast & Price Target

Morgan Stanley logo
$155.63 -0.34 (-0.22%)
Closing price 10/8/2025 03:59 PM Eastern
Extended Trading
$155.72 +0.09 (+0.06%)
As of 05:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
9
Buy
8

Based on 17 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 9 have given a hold rating, 6 have given a buy rating, and 2 have given a strong buy rating for MS.

Consensus Price Target

$154.85
-0.50% Downside
According to the 17 analysts' twelve-month price targets for Morgan Stanley, the average price target is $154.85. The highest price target for MS is $180.00, while the lowest price target for MS is $122.00. The average price target represents a forecasted downside of -0.50% from the current price of $155.63.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MS Analyst Ratings Over Time

TypeCurrent Forecast
10/9/24 to 10/9/25
1 Month Ago
9/9/24 to 9/9/25
3 Months Ago
7/11/24 to 7/11/25
1 Year Ago
10/10/23 to 10/9/24
Strong Buy
2 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
5 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
10 Hold rating(s)
12 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$154.85$138.25$136.69$103.06
Forecasted Upside-0.50% Downside-9.18% Downside-3.91% Downside-5.48% Downside
Consensus RatingModerate BuyHoldHoldHold

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Morgan Stanley Stock vs. The Competition

TypeMorgan StanleyFinance CompaniesS&P 500
Consensus Rating Score
2.59
2.30
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside-0.50% Downside120.50% Upside170.76% Upside
News Sentiment Rating
Very Positive News

See Recent MS News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/8/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingBuy (B-)
10/7/2025UBS Group
4 of 5 stars
Erika Najarian
Erika Najarian
Not Rated
Boost TargetNeutral$156.00 ➝ $165.00+5.60%
10/3/2025The Goldman Sachs Group
3 of 5 stars
Richard Ramsden
Not Rated
Boost TargetNeutral$145.00 ➝ $164.00+4.24%
10/3/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$180.00+15.92%
10/1/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetSector Perform$145.00 ➝ $171.00+8.64%
9/30/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$150.00 ➝ $165.00+2.45%
9/26/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$130.00 ➝ $155.00-2.49%
9/16/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetEqual Weight$145.00 ➝ $165.00+5.36%
7/9/2025Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeMarket PerformOutperform$127.00 ➝ $160.00+13.35%
5/24/2025Erste Group Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
4/14/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetNeutral$125.00 ➝ $122.00+11.89%
4/14/2025JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform
4/2/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetBuy$150.00 ➝ $144.00+24.33%
1/17/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$155.00 ➝ $156.00+13.27%
11/26/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
11/26/2024HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyHold$128.00 ➝ $131.00-2.00%
10/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$120.00 ➝ $135.00+12.69%
7/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeOutperformMarket Perform
4/16/2024Cfra
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$97.00 ➝ $108.00+20.82%
11/28/2023Societe Generale
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyHold$80.00+2.63%
11/20/2023BNP Paribas
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeOutperformNeutral$85.00+5.88%
10/23/2023Odeon Capital Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyHold$79.15+8.72%
10/20/2023Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeUnderperformPeer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:39 AM ET.


Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 7, 2025. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Morgan Stanley:

  • The current stock price is around $157, indicating a potential upside based on recent price targets set by analysts.
  • Recent earnings reports show that Morgan Stanley exceeded consensus estimates, with earnings per share significantly higher than expected, reflecting strong financial performance.
  • The company has initiated a substantial stock repurchase program, allowing for the buyback of up to $20 billion in shares, which often signals that management believes the stock is undervalued.
  • Analysts have recently upgraded their price targets for Morgan Stanley, with several firms projecting targets above the current stock price, suggesting positive market sentiment.
  • The firm has increased its quarterly dividend to $1.00 per share, representing a solid annual yield, which can attract income-focused investors.

Morgan Stanley
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Morgan Stanley for these reasons:

  • The company has a relatively high debt-to-equity ratio of 3.30, which may indicate increased financial risk compared to its equity base.
  • Despite recent positive earnings, the current economic environment poses uncertainties that could impact future performance and profitability.
  • Market volatility can affect financial services firms like Morgan Stanley, leading to fluctuations in stock performance that may deter risk-averse investors.
  • Analysts have issued a mix of ratings, with some maintaining a "neutral" stance, suggesting that not all market participants are confident in the stock's growth potential.
  • The company's quick and current ratios are both at 0.78, indicating potential liquidity concerns, which could affect its ability to meet short-term obligations.

MS Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $154.85, with a high forecast of $180.00 and a low forecast of $122.00.

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last twelve months. There are currently 9 hold ratings, 6 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MS shares.

According to analysts, Morgan Stanley's stock has a predicted downside of -0.50% based on their 12-month stock forecasts.

Over the previous 90 days, Morgan Stanley's stock had 1 upgrade by analysts.

Morgan Stanley has been rated by research analysts at BMO Capital Markets, Citigroup, Evercore ISI, Royal Bank Of Canada, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.

Analysts like Morgan Stanley more than other "finance" companies. The consensus rating for Morgan Stanley is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MS compares to other companies.


This page (NYSE:MS) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners